Show simple item record

dc.contributor.authorBarry, Eileen
dc.contributor.authorCassels, Fred
dc.contributor.authorRiddle, Mark
dc.creatorBarry, E.
dc.date.accessioned2019-08-02T14:31:46Z
dc.date.available2019-08-02T14:31:46Z
dc.date.issued2019-08-07
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85063382460&origin=inward
dc.identifier.urihttp://hdl.handle.net/10713/10144
dc.description.abstractPATH hosted the second Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference in Mexico City in June 2018, again providing experts from around the world an opportunity to participate in a highly collaborative forum to discuss progress in the development of new enteric vaccines. Through a combination of plenary sessions and posters, keynote presentations, and workshops, the 2018 VASE Conference aimed to accelerate communication and progress among those working to achieve the goal of licensed vaccines against these two bacterial pathogens. Many presentations recognized the importance of diarrheal disease and long-term sequelae caused by infections with Shigella and enterotoxigenic E. coli (ETEC). Other presentations explored new strategies for vaccine development, including the search for novel, possibly conserved, antigens for more effective vaccines. Much progress is being made as some vaccine candidates are now moving through clinical trials. Research presented in oral and poster presentations at the VASE Conference covered a range of topics, including: the global burden of disease, epidemiology, and health economics; host parameters and genomics that predict responses to infection and disease; preclinical evaluations of vaccine antigens and models of enteric diseases; and vaccine candidates in clinical trials and human challenge studies. This article reviews key points and highlighted research presented in each of the plenary conference sessions and poster presentations at the 2018 VASE Conference. © 2019 The Authorsen_US
dc.description.urihttps://doi.org/10.1016/j.vaccine.2019.02.070en_US
dc.language.isoen_USen_US
dc.publisherElsevier Ltd.en_US
dc.relation.ispartofVaccineen_US
dc.subjectDiarrheaen_US
dc.subjectETECen_US
dc.subjectImmunizationen_US
dc.subjectShigellaen_US
dc.subjectStuntingen_US
dc.subjectVaccinesen_US
dc.titleVaccines Against Shigella and Enterotoxigenic Escherichia coli: A summary of the 2018 VASE Conferenceen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.vaccine.2019.02.070
dc.relation.volume37


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record